Repare Therapeutics Email Format
Biotechnology ResearchQuebec, Canada11-50 Employees
Repare Therapeutics is a clinical-stage biotechnology company headquartered in Montreal, Quebec, Canada, focused on precision oncology. It pursues a synthetic lethality–based approach to discovering and developing targeted cancer therapies, leveraging its genome-wide, CRISPR-enabled SNIPRx platform to address genomic instability, including DNA damage repair pathways. The company was founded in 2016 by leading academics to systematically translate synthetic lethality insights into new medicines. It employs 11-50 people. Reported revenue is in the range of $50–100 million.
1-888-653-2347 
support@leadiq.com 
